Clinical Trials on Partially Edentulous Maxilla, Partially Edentulous Mandible in India
Total 1 results
-
University of ZurichITI FoundationNot yet recruiting
Sponsors and Collaborators
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Julian Taylor Green
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- United States Department of Defense (DOD)
- Foshan Sanshui District People's Hospital
- Paulo Sérgio Gomes Nogueira Borges
- Korea Otsuka International Asia Arab
- Plethora Solutions Ltd
- University of Applied Sciences Jena
- Lilly PharmaceuticalCompany
- Oblikue Consulting
- Gunkang Pharmaceuticals, Inc
- S-Biotek Holding ApS
- Eurotrials Brasil Consultores Cientificos Ltda
- Rivierduinen, Centre for Personality disorders Jelgersma
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Iyad Naeem Muhammad, PhD
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Arsha Vidya Tirtha
- Sudimplant SAS - Groupe TBR
- View Full List
Medical Conditions
- Thyroid and Parathyroid Surgery
- Deformity Flexion
- Advance Directive Completion
- Blepharospasm of Both Eyelids
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Visual Attention Span Deficit
- Malaria,Falciparum
- Huntington Chorea
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Immunologically-induced Lung Disease
- Testicular Teratoma
- Vibration; Exposure
- Anemia Acute
- Puberty, Delayed
- Chemotherapy-Induced Neutropenia
- Serum Albumin Low
- Hypothermia Following Anesthesia, Sequela
- Gray Platelet Syndrome
- Brain Tumor, Primary
- View Full List
Drug Interventions
- Vosaroxin
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- F520
- Mineralocorticoid receptor antagonist
- Rovalpituzumab tesirine
- Celecoxib
- MMV390048 120mg
- Pemetrexed
- S-Adenosyl-Methionine
- Furmonertinib 160 mg
- Bimatoprost 0.03% eye drops
- Standard medical therapy
- Pegfilgrastim
- Cyanoacrylate
- ABY-035 i.v.
- Ebselen
- Oxycodone
- Cytisine
- Sorafenib
- Acalabrutinib in combination with VR
- View Full List
CROs by country
- Contract Research Organizations in Austria
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Chile
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Malawi
- Contract Research Organizations in Poland
- Contract Research Organizations in Portugal
- Contract Research Organizations in Senegal
- Contract Research Organizations in United Kingdom
- Contract Research Organizations in United States
- CRO list by country